Resolved and unresolved issues of cerebrovascular disease in diabetes mellitus

Significant contribution of type 2 diabetes mellitus (T2DM) to the development and progression of cerebrovascular disease (CVD) has been confirmed over the past few decades. The aim of this article is to present the results of many years of research, summarizing generally resolved problems in CVD an...

Full description

Bibliographic Details
Main Authors: Мarine М. Tanashyan, Kseniya V. Antonova, Оlga V. Lagoda, Аlla А. Shabalina
Format: Article
Language:English
Published: Research Center of Neurology 2021-10-01
Series:Анналы клинической и экспериментальной неврологии
Subjects:
Online Access:https://annaly-nevrologii.com/journal/pathID/article/viewFile/756/583
_version_ 1818217149044359168
author Мarine М. Tanashyan
Kseniya V. Antonova
Оlga V. Lagoda
Аlla А. Shabalina
author_facet Мarine М. Tanashyan
Kseniya V. Antonova
Оlga V. Lagoda
Аlla А. Shabalina
author_sort Мarine М. Tanashyan
collection DOAJ
description Significant contribution of type 2 diabetes mellitus (T2DM) to the development and progression of cerebrovascular disease (CVD) has been confirmed over the past few decades. The aim of this article is to present the results of many years of research, summarizing generally resolved problems in CVD and T2DM comorbidity, as well as raising several issues that still need to be clarified. Materials and methods. The assessment results of 824 patients with CVD were selected from a large body of data for inclusion in the analysis. Ischaemic stroke was analysed in 250 patients: 128 patients with T2DM (aged 63 [54; 74] years) and 122 patients without T2DM (62 [52; 71] years). The group with chronic CVD consisted of 574 people: 300 patients with T2DM (62 [56; 69] years) and 274 patients without T2DM (63 [57; 68] years). The results of surgery for carotid artery stenosis were evaluated in 170 patients, including 72 patients with T2DM. The control group consisted of 86 persons without CVD (60 [54; 63] years). A wide range of clinical, laboratory and imaging assessments included physical and neurological examinations, neuropsychological tests, blood chemistry, haemorheological and haemostasis tests, as well as neuroimaging studies. Results. T2DM has a significant effect on neurological, neuropsychological, cognitive and functional impairments, as well as on the outcome of acute and chronic CVD, progression of intracranial atherosclerotic lesions, and changes in cerebral and vascular tissue. The impact of the quality of glycaemic control and duration of chronic hyperglycaemia on neurocognitive and structural brain changes has not been completely determined yet. The role of non-glycaemic changes, including influence of several mediators on the vascular and neurodegenerative mechanisms of cerebral tissue damage, warrants further study. Conclusion. The obtained results identify a wide range of unanswered questions and emphasize the need for both possible changes to several clinical algorithms and for ongoing in-depth studies of CVD associated with T2DM.
first_indexed 2024-12-12T07:03:16Z
format Article
id doaj.art-8ae57e7412464ab294501385b21951fe
institution Directory Open Access Journal
issn 2075-5473
2409-2533
language English
last_indexed 2024-12-12T07:03:16Z
publishDate 2021-10-01
publisher Research Center of Neurology
record_format Article
series Анналы клинической и экспериментальной неврологии
spelling doaj.art-8ae57e7412464ab294501385b21951fe2022-12-22T00:33:48ZengResearch Center of NeurologyАнналы клинической и экспериментальной неврологии2075-54732409-25332021-10-0115351410.54101/ACEN.2021.3.1560Resolved and unresolved issues of cerebrovascular disease in diabetes mellitusМarine М. Tanashyan0https://orcid.org/0000-0002-5883-8119Kseniya V. Antonova1https://orcid.org/0000-0003-2373-2231Оlga V. Lagoda2https://orcid.org/0000-0001-7562-4991Аlla А. Shabalina3https://orcid.org/0000-0001-9604-7775Research Center of NeurologyResearch Center of NeurologyResearch Center of NeurologyResearch Center of NeurologySignificant contribution of type 2 diabetes mellitus (T2DM) to the development and progression of cerebrovascular disease (CVD) has been confirmed over the past few decades. The aim of this article is to present the results of many years of research, summarizing generally resolved problems in CVD and T2DM comorbidity, as well as raising several issues that still need to be clarified. Materials and methods. The assessment results of 824 patients with CVD were selected from a large body of data for inclusion in the analysis. Ischaemic stroke was analysed in 250 patients: 128 patients with T2DM (aged 63 [54; 74] years) and 122 patients without T2DM (62 [52; 71] years). The group with chronic CVD consisted of 574 people: 300 patients with T2DM (62 [56; 69] years) and 274 patients without T2DM (63 [57; 68] years). The results of surgery for carotid artery stenosis were evaluated in 170 patients, including 72 patients with T2DM. The control group consisted of 86 persons without CVD (60 [54; 63] years). A wide range of clinical, laboratory and imaging assessments included physical and neurological examinations, neuropsychological tests, blood chemistry, haemorheological and haemostasis tests, as well as neuroimaging studies. Results. T2DM has a significant effect on neurological, neuropsychological, cognitive and functional impairments, as well as on the outcome of acute and chronic CVD, progression of intracranial atherosclerotic lesions, and changes in cerebral and vascular tissue. The impact of the quality of glycaemic control and duration of chronic hyperglycaemia on neurocognitive and structural brain changes has not been completely determined yet. The role of non-glycaemic changes, including influence of several mediators on the vascular and neurodegenerative mechanisms of cerebral tissue damage, warrants further study. Conclusion. The obtained results identify a wide range of unanswered questions and emphasize the need for both possible changes to several clinical algorithms and for ongoing in-depth studies of CVD associated with T2DM.https://annaly-nevrologii.com/journal/pathID/article/viewFile/756/583cerebrovascular diseasetype 2 diabetes mellituscarotid atherosclerosiscognitive disordershemorheologybiochemistry
spellingShingle Мarine М. Tanashyan
Kseniya V. Antonova
Оlga V. Lagoda
Аlla А. Shabalina
Resolved and unresolved issues of cerebrovascular disease in diabetes mellitus
Анналы клинической и экспериментальной неврологии
cerebrovascular disease
type 2 diabetes mellitus
carotid atherosclerosis
cognitive disorders
hemorheology
biochemistry
title Resolved and unresolved issues of cerebrovascular disease in diabetes mellitus
title_full Resolved and unresolved issues of cerebrovascular disease in diabetes mellitus
title_fullStr Resolved and unresolved issues of cerebrovascular disease in diabetes mellitus
title_full_unstemmed Resolved and unresolved issues of cerebrovascular disease in diabetes mellitus
title_short Resolved and unresolved issues of cerebrovascular disease in diabetes mellitus
title_sort resolved and unresolved issues of cerebrovascular disease in diabetes mellitus
topic cerebrovascular disease
type 2 diabetes mellitus
carotid atherosclerosis
cognitive disorders
hemorheology
biochemistry
url https://annaly-nevrologii.com/journal/pathID/article/viewFile/756/583
work_keys_str_mv AT marinemtanashyan resolvedandunresolvedissuesofcerebrovasculardiseaseindiabetesmellitus
AT kseniyavantonova resolvedandunresolvedissuesofcerebrovasculardiseaseindiabetesmellitus
AT olgavlagoda resolvedandunresolvedissuesofcerebrovasculardiseaseindiabetesmellitus
AT allaashabalina resolvedandunresolvedissuesofcerebrovasculardiseaseindiabetesmellitus